To determine the expression of MYC following PI3Kβ/δ inhibition, we treated two AZD8186-sensitive (HT and K422) and two insensitive (WSUDLCL2 and OCI-Ly2) GCB DLBCL models with AZD8186 and visualized MYC protein levels by immunoblotting. The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.